Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Medical Probiotics Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Medical Probiotics Market Status and Forecast (2016-2027)
      • 1.3.2 Global Medical Probiotics Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Medical Probiotics Supply by Company

    • 2.1 Global Medical Probiotics Sales Volume by Company
    • 2.2 Global Medical Probiotics Sales Value by Company
    • 2.3 Global Medical Probiotics Price by Company
    • 2.4 Medical Probiotics Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Medical Probiotics Market Status by Category

    • 3.1 Medical Probiotics Category Introduction
      • 3.1.1 Bifidobacterium
      • 3.1.2 Lactobacillus
      • 3.1.3 Others
    • 3.2 Global Medical Probiotics Market by Category
      • 3.2.1 Global Medical Probiotics Sales Volume by Category (2016-2021)
      • 3.2.2 Global Medical Probiotics Sales Value by Category (2016-2021)
      • 3.2.3 Global Medical Probiotics Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Medical Probiotics Market Status by End User/Segment

    • 4.1 Medical Probiotics Segment by End User/Segment
      • 4.1.1 Pharmaceuticals
      • 4.1.2 Dietary Supplements
      • 4.1.3 Others
    • 4.2 Global Medical Probiotics Market by End User/Segment
      • 4.2.1 Global Medical Probiotics Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Medical Probiotics Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Medical Probiotics Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Medical Probiotics Market Status by Region

    • 5.1 Global Medical Probiotics Market by Region
      • 5.1.1 Global Medical Probiotics Sales Volume by Region
      • 5.1.2 Global Medical Probiotics Sales Value by Region
    • 5.2 North America Medical Probiotics Market Status
    • 5.3 Europe Medical Probiotics Market Status
    • 5.4 Asia Pacific Medical Probiotics Market Status
    • 5.5 Central & South America Medical Probiotics Market Status
    • 5.6 Middle East & Africa Medical Probiotics Market Status

    6 North America Medical Probiotics Market Status

    • 6.1 North America Medical Probiotics Market by Country
      • 6.1.1 North America Medical Probiotics Sales Volume by Country (2016-2021)
      • 6.1.2 North America Medical Probiotics Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Medical Probiotics Market Status

    • 7.1 Europe Medical Probiotics Market by Country
      • 7.1.1 Europe Medical Probiotics Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Medical Probiotics Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Medical Probiotics Market Status

    • 8.1 Asia Pacific Medical Probiotics Market by Country
      • 8.1.1 Asia Pacific Medical Probiotics Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Medical Probiotics Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Medical Probiotics Market Status

    • 9.1 Central & South America Medical Probiotics Market by Country
      • 9.1.1 Central & South America Medical Probiotics Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Medical Probiotics Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Medical Probiotics Market Status

    • 10.1 Middle East & Africa Medical Probiotics Market by Country
      • 10.1.1 Middle East & Africa Medical Probiotics Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Medical Probiotics Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Medical Probiotics Manufacturing Cost Analysis
    • 11.5 Medical Probiotics Sales Channel and Distributors Analysis
      • 11.5.1 Medical Probiotics Sales Channel
      • 11.5.2 Medical Probiotics Distributors
    • 11.6 Medical Probiotics Downstream Major Buyers

    12 Global Medical Probiotics Market Forecast by Category and by End User/Segment

    • 12.1 Global Medical Probiotics Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Medical Probiotics Forecast by Category
      • 12.2.1 Global Medical Probiotics Sales Volume Forecast by Category
      • 12.2.2 Global Medical Probiotics Sales Value Forecast by Category
      • 12.2.3 Global Medical Probiotics Price Forecast by Category
    • 12.3 Global Medical Probiotics Forecast by End User/Segment
      • 12.3.1 Global Medical Probiotics Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Medical Probiotics Sales Value Forecast by End User/Segment
      • 12.3.3 Global Medical Probiotics Price Forecast by End User/Segment

    13 Global Medical Probiotics Market Forecast by Region/Country

    • 13.1 Global Medical Probiotics Market Forecast by Region (2022-2027)
      • 13.1.1 Global Medical Probiotics Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Medical Probiotics Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Winclove Probiotics
      • 14.1.1 Company Information
      • 14.1.2 Medical Probiotics Product Introduction
      • 14.1.3 Winclove Probiotics Medical Probiotics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Unique Biotech
      • 14.2.1 Company Information
      • 14.2.2 Medical Probiotics Product Introduction
      • 14.2.3 Unique Biotech Medical Probiotics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 UAS Laboratories
      • 14.3.1 Company Information
      • 14.3.2 Medical Probiotics Product Introduction
      • 14.3.3 UAS Laboratories Medical Probiotics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Synbiotech
      • 14.4.1 Company Information
      • 14.4.2 Medical Probiotics Product Introduction
      • 14.4.3 Synbiotech Medical Probiotics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Probi
      • 14.5.1 Company Information
      • 14.5.2 Medical Probiotics Product Introduction
      • 14.5.3 Probi Medical Probiotics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Novozymes
      • 14.6.1 Company Information
      • 14.6.2 Medical Probiotics Product Introduction
      • 14.6.3 Novozymes Medical Probiotics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Nestle
      • 14.7.1 Company Information
      • 14.7.2 Medical Probiotics Product Introduction
      • 14.7.3 Nestle Medical Probiotics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Lallemand
      • 14.8.1 Company Information
      • 14.8.2 Medical Probiotics Product Introduction
      • 14.8.3 Lallemand Medical Probiotics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Glory Biotech
      • 14.9.1 Company Information
      • 14.9.2 Medical Probiotics Product Introduction
      • 14.9.3 Glory Biotech Medical Probiotics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Ganeden
      • 14.10.1 Company Information
      • 14.10.2 Medical Probiotics Product Introduction
      • 14.10.3 Ganeden Medical Probiotics Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 DSM
    • 14.12 DowDuPont
    • 14.13 Danone
    • 14.14 Chr. Hansen
    • 14.15 China-Biotics
    • 14.16 BioGaia

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Medical Probiotics market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Medical Probiotics market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Bifidobacterium
      Lactobacillus
      Others

      Segmented by End User/Segment
      Pharmaceuticals
      Dietary Supplements
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Winclove Probiotics
      Unique Biotech
      UAS Laboratories
      Synbiotech
      Probi
      Novozymes
      Nestle
      Lallemand
      Glory Biotech
      Ganeden
      DSM
      DowDuPont
      Danone
      Chr. Hansen
      China-Biotics
      BioGaia

      Buy now